Date: April 15, 2022 By: Paul Goldsmith
When world-record holding marathoner Susan Ragon hit a bump in the road, she looked to Massachusetts General Hospital. In turn, her generosity and tenacity has inspired others in the Mass General community to lace up and join “Team Susan.”
Read about Susan Ragon’s passion for running and how she inspired her care team at Mass General to run marathons too: https://giving.massgeneral.org/stories/running-the-marathon-of-life
Researchers at the Ragon Institute have developed a novel immunization strategy that shows promise for protecting against both group 1 and group 2 influenza A viruses. The strategy, detailed in their recent study, relies on eliciting a single amino acid change in antibodies to generate broadly neutralizing antibodies (bnAbs).
Their findings, to be published in Cell next month, reveal how the virus manipulates immune system processes to avoid destruction by natural killer (NK) cells, a type of white blood cell that is crucial for fighting viral infections.
The lab of the Ragon Institute faculty member Hernandez Moura Silva, PhD, recently published a review in Science Immunology regarding resident tissue macrophages (RTMs), shedding light on their multifaceted roles in organ health.